The specific receptor domain is the extracellular V-C1-C2 portion of the RAGE receptor. S100B functions as a prognostic marker because its expression level correlates directly with the downstream pathways that cause neuroinflammation, neuronal loss, and neurodegeneration, thereby predicting the severity and progression of the neurological disorder.